199 Results for "

AT

" in MedChemExpress (MCE) Product Catalog:
Products (199)

199 Results for "AT" in MCE Product Catalog:

Cat. No.: HY-112375
CAS No.: 2098836-50-9
Purity:  99.59%
Research Areas:  

Cancer

AT6 is a PROTAC AT1 analogue, which is a PROTAC connected by an E3 ligand for von Hippel-Lindau and a ligand for BRD4 with highly selectivity to bromodomain (Brd4).
loading...
    loading...
Cat. No.: HY-114426A
Purity:  99.51%
Target:  

Gap Junction Protein

Research Areas:  

Metabolic Disease

AT-1002 TFA, a 6-mer synthetic peptide , is a tight junction regulator and absorption enhancer .
loading...
    loading...
Cat. No.: HY-112692
CAS No.: 2099681-31-7
Purity:  ≥96.0%
Target:  

Opioid Receptor

Research Areas:  

Neurological Disease

AT-121 is a bifunctional nociception and mu opioid receptor agonist, with Kis of 3.67 and 16.49 nM, respectively. AT-121 is a safe, non-addictive analgesic, and shows antinociceptive and antiallodynic effects .
loading...
    loading...
Cat. No.: HY-156597
CAS No.: 1998705-63-7
Purity:  99.88%
Synonyms: AT-752 free base
Research Areas:  

Infection

Arbemnifosbuvir (AT-752 free base) is an orally active inhibitor of DENV NS5 RdRp and MTase, and is also a guanosine nucleotide analog prodrug. Arbemnifosbuvir forms the active triphosphate metabolite AT‑9010 (HY-139165) in peripheral blood mononuclear cells, which competes with GTP to terminate RNA synthesis and binds to the GTP/RNA-cap site to inhibit 2'-O-methylation. Arbemnifosbuvir reduces viremia, improves survival, prevents weight loss, and decreases viral load in a mouse model of dengue virus. Arbemnifosbuvir can be used for research related to viral infections .
loading...
    loading...
Cat. No.: HY-15241
CAS No.: 902156-99-4
Purity:  98.81%
Synonyms: LCQ-195; AT9311
Target:  

CDK

Research Areas:  

Cancer

NVP-LCQ195 (LCQ-195) is an inhibitor of CDK1/2/3/5/9. NVP-LCQ195 induces cell cycle arrest and eventual apoptotic cell death of multiple myeloma (MM) cells. NVP-LCQ195 triggers decreased amplitude of transcriptional signatures related to oncogenesis, drug resistance and stem cell renewal in MM cell lines .
loading...
    loading...
Cat. No.: HY-18967
CAS No.: 1355612-71-3
Synonyms: AT-001; Aldose reductase-IN-1
Target:  

Aldose Reductase

Research Areas:  

Metabolic Disease

Caficrestat (AT-001) is an orally active aldose reductase inhibitor. Caficrestat can be used in the study of diabetic cardiomyopathy .
loading...
    loading...
Cat. No.: HY-148877
CAS No.: 908112-37-8
Purity:  98.86%
AT-533 is a potent Hsp90 and HSV inhibitor. AT-533 suppresses tumor growth and angiogenesis by blocking the HIF-1α/VEGF/VEGFR-2 signaling pathway. AT-533 also inhibits the activation of the downstream pathways, including Akt/mTOR/p70S6K, Erk1/2 and FAK. AT-533 inhibits the tube formation, cell migration, and invasion of human umbilical vein endothelial cells (HUVECs) .
loading...
    loading...
Cat. No.: HY-114426
CAS No.: 835872-35-0
Target:  

Gap Junction Protein

Research Areas:  

Metabolic Disease

AT-1002, a 6-mer synthetic peptide , is a tight junction regulator and absorption enhancer .
loading...
    loading...
Cat. No.: HY-113916
CAS No.: 1019889-35-0
Synonyms: AT13387 lactATe
Target:  

HSP

Research Areas:  

Cancer

Onalespib lactate is a potent and cross the blood-brain barrier heat-shock-protein-90 (Hsp90) inhibitor with an Kd value of 0.71 nM. Onalespib lactate inhibits the proliferation, survival and migration. Onalespib lactate decreases the expression of EGFR, p-EGFR, AKT, P-AKT, ERK1/2, P-ERK1/2, S6, P-S6 protein. Onalespib lactate shows antitumor activity. Onalespib lactate has the potential for the research of non-small cell lung cancer (NSCLC) .
loading...
    loading...
Cat. No.: HY-P991532
Synonyms: MEMD; EJ212/007-Cl2-5

Target:  

ALCAM/CD166

Research Areas:  

Inflammation/Immunology Cancer

AT002 (CBAS-173, EJ212/007-Cl2-5) is a recombinant human IgG1 monoclonal antibody. AT002 targets the cell surface protein activated leukocyte adhesion molecule (ALCAM)/CD166. AT002 can be used in the research of cancer, autoimmune diseases and inflammatory diseases.
loading...
    loading...
Cat. No.: HY-139165
CAS No.: 1261253-79-5
Target:  

SARS-CoV

Research Areas:  

Infection

AT-9010, a triphosphate active metabolite of AT-527, is a potent inhibitor of NiRAN (a function essential for viral replication). AT-9010 can inhibit SARS-CoV-2 replication .
loading...
    loading...
Cat. No.: HY-13988R
CAS No.: 162640-98-4
Research Areas:  

Inflammation/Immunology

AT-56 (Standard) is the analytical standard of AT-56. This product is intended for research and analytical applications. AT-56 is a potent, selective and orally active inhibitor of lipocalin-type prostaglandin D synthase (L-PGDS), with an IC50 of 95 μM and Ki of 75 μM. AT-56 could selectively suppress the drowsiness or pain reaction mediated by L-PGDS-catalyzed PGD2 .
loading...
    loading...
Cat. No.: HY-19015
CAS No.: 95604-83-4
Synonyms: AT-2153
Target:  

Calmodulin

Research Areas:  

Cancer

Probimane (AT-2153) is a potent anticancer agent. Probimane is effective against mouse tumors S37, S180, Lewis lung carcinoma, L1210 and human pulmonary adenocarcinoma heterotransplanted into nude mice .
loading...
    loading...
Cat. No.: HY-50940R
CAS No.: 844442-38-2
Synonyms: AT7519M (Standard)
Research Areas:  

Cancer

AT7519 (Standard) is the analytical standard of AT7519. This product is intended for research and analytical applications. AT7519 (AT7519M) as a potent inhibitor of CDKs, with IC50s of 210, 47, 100, 13, 170, and <10 nM for CDK1, CDK2, CDK4 to CDK6, and CDK9, respectively.
loading...
    loading...
Cat. No.: HY-10057
CAS No.: 896466-61-8
Target:  

Aurora Kinase

Research Areas:  

Cancer

AT9283 hydrochloride is a multi-targeted kinase inhibitor with anti-tumor activity. AT9283 hydrochloride has been found to effectively inhibit Aurora A and Aurora B kinases, thereby affecting cell proliferation and survival. AT9283 hydrochloride can also inhibit several other kinases, including JAK2 and Abl (T315I) .
loading...
    loading...
Cat. No.: HY-106732
CAS No.: 1657028-64-2
Target:  

Opioid Receptor

Research Areas:  

Neurological Disease

AT-076 is an opioid pan antagonist at nociception, kappa, mu, and delta opioid receptors, with Ki values of 1.75 nM (NOP), 1.67 nM (MOP), 1.14 nM (KOP) and 19.6 nM (DOP), respectively .
loading...
    loading...
Cat. No.: HY-112692A
CAS No.: 2099681-71-5
Target:  

Opioid Receptor

Research Areas:  

Neurological Disease

AT-121 hydrochloride is a bifunctional nociception and mu opioid receptor agonist, with Kis of 3.67 and 16.49 nM, respectively. AT-121 hydrochloride is a safe, non-addictive analgesic, and shows antinociceptive and antiallodynic effects .
loading...
    loading...
Cat. No.: HY-156992
CAS No.: 2099680-55-2
Target:  

Opioid Receptor

Research Areas:  

Neurological Disease

AT-035 is a high affinity and selective NOP agonist .
loading...
    loading...
Cat. No.: HY-P991575

Research Areas:  

Cancer

AT003 is a humanized monoclonal antibody targeting EpCAM/TROP1/CD326. AT003 can be used for synthesis of ADC .
loading...
    loading...
Cat. No.: HY-10058
CAS No.: 896466-76-5
Research Areas:  

Cancer

AT9283 lactic acid is a multi-targeted kinase inhibitor with potent activity against Aurora A/B, JAK2/3, Abl (T315I) and Flt3 (IC50s ranging from 1 to 30 nM). AT9283 lactic acid inhibits growth and survival of multiple solid tumors in vitro and in vivo .
loading...
    loading...